Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zsolt Székelyhidi"'
Autor:
Péter, Bánhegyi, Frigyes, Wáczek, Zsolt, Székelyhidi, Bálint, Hegymegi-Barakonyi, György, Kéri, László, Orfi
Publikováno v:
Acta pharmaceutica Hungarica. 78(2)
We planned and prepared a kinase inhibitor focused compound library around the 1-benzotiophene core structure, but the 2-acylamino-1-benzotiophene-3-carboxylic acid ethyl ester derivatives could not be converted to amides by the traditional methods l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be82ea11d2567d683b4592a19616b6ee
https://pubmed.ncbi.nlm.nih.gov/18807387
https://pubmed.ncbi.nlm.nih.gov/18807387
Autor:
Zoltan Bajko, Laszlo Uerge, Ildiko Kovacs, Zsolt Székelyhidi, Ferenc Darvas, Bernadett Borcsek, Krisztian Niesz, Csaba Csajági
Publikováno v:
ChemInform. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69681690ee89e6716aaa2e44f09e1263
https://doi.org/10.1002/chin.200834082
https://doi.org/10.1002/chin.200834082
Autor:
Zsolt, Székelyhidi, János, Pató, Bálint, Hegymegi-Barakonyi, Péter, Bánhegyi, György, Mészáros, György, Kéri, Lászlo, Orfi
Publikováno v:
Acta pharmaceutica Hungarica. 75(4)
We have synthesised a series of known alpha-terthiophene lead molecules with PKC (protein kinase C) inhibitory activity and the compounds were tested in cell proliferation assay on EGF-RTK (epidermal growth factor receptor protein tyrosine kinase) ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0067f830cc5d49f69f147a853843fff2
https://pubmed.ncbi.nlm.nih.gov/16711395
https://pubmed.ncbi.nlm.nih.gov/16711395
Autor:
Doris Hafenbradl, Laszlo Orfi, György Kéri, Péter Bánhegyi, István Varga, Gerhard Müller, Zoltán Varga, János Pató, Axel Ullrich, Ildikó Szilágyi, Zsolt Székelyhidi, Zoltán Horváth, Dániel Eros, Jenö Marosfalvi, Zoltán Greff, Bálint Hegymegi-Barakonyi, Frigyes Wáczek, Csaba Szántai-Kis, Bert Klebl, István Szabadkai, Zsolt Szegedi
Publikováno v:
Assay and drug development technologies. 3(5)
Kinase inhibitors are at the forefront of modern drug research, where mostly three technologies are used for hit-and-lead finding: high throughput screening of random libraries, three-dimensional structure-based drug design based on X-ray data, and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e92b1b9b53e7629e96fbd0a96760104
https://pubmed.ncbi.nlm.nih.gov/16305311
https://pubmed.ncbi.nlm.nih.gov/16305311
Autor:
Csaba Csajági, Bernadett Borcsek, Krisztián Niesz, Ildikó Kovács, Zsolt Székelyhidi, Zoltán Bajkó, László Ürge, Ferenc Darvas
Publikováno v:
Organic Letters; Apr2008, Vol. 10 Issue 8, p1589-1592, 4p
Autor:
György Kéri, Zsolt Székelyhidi, Péter Bánhegyi, Zoltán Varga, Bálint Hegymegi-Barakonyi, Csaba Szántai-Kis, Doris Hafenbradl, Bert Klebl, Gerhard Muller, Axel Ullrich, Dániel Erös, Zoltán Horváth, Zoltán Greff, Jenö Marosfalvi, János Pató, István Szabadkai, Ildikó Szilágyi, Zsolt Szegedi, István Varga, Frigyes Wáczek
Publikováno v:
Assay & Drug Development Technologies; Oct2005, Vol. 3 Issue 5, p543-551, 9p